Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DocuSign, Inc. - Common Stock (NQ:DOCU)

83.29 -0.85 (-1.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DocuSign, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
37 38 Next >
Fiverr International, DocuSign, GE And This Leading Casino Company: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Fiverr International Ltd. (NYSE: FVRR) is a profitable company, having a market capitalization of over $1 billion. 
Via Benzinga
What Does 2023 Have in Store for Growth Stocks, Electric Vehicles, and More?
It's time to lawyer up! 
Via The Motley Fool
Vail Resorts, DocuSign And This Leading Homebuilding Stock Trading 9 Times Earnings On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said Vail Resorts, Inc. (NYSE: MTN) is a company with a high debt load. 
Via Benzinga
Down 61% to 71%, These Colossal Growth Stocks Could Be Ready for a Surge
Business growth will eventually win over the current bearish sentiment. 
Via The Motley Fool
Companies Still SOIL-ing Themselves
A better way to define stock-based compensation is to call it secondary stock offerings in lieu of cash expenses (SSOILCE) or what I will abbreviate to SOIL (stock offering in lieu). 
Via Talk Markets
DocuSign Stock: Buy, Sell, or Hold in 2023?
DocuSign beat estimates in Q3 but is still unprofitable. 
Via The Motley Fool
Why Is Everyone Talking About DocuSign Stock?
The electronic signature provider is at the top of stock market investors' minds. 
Via The Motley Fool
Citigroup Maintains Buy Rating for DocuSign: Here's What You Need To Know
Via Benzinga
Cloud Stocks: DocuSign Focuses On Diversifying Portfolio
Recently eSignature player DocuSign announced its third-quarter results that surpassed market expectations. The company is looking to expand its use cases and diversify its product category to drive... 
Via Talk Markets
1 Superb Stock Down 84% That's Set to Soar Next Year
DocuSign is dealing with an entirely different world than the one that boosted its business at the height of the pandemic. 
Via The Motley Fool
Stocks Hold Gains Ahead Of Tuesday's Economic Flurry
The major indexes are continuing their move higher this afternoon, as investors await tomorrow's release of November's consumer price index (CPI) data. 
Via Talk Markets
Looking At DocuSign's Recent Unusual Options Activity
Someone with a lot of money to spend has taken a bullish stance on DocuSign (NASDAQ:DOCU). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
DocuSign Stock Just Got a Whole Lot More Interesting -- or Did It?
Investors should not jump the gun just yet. 
Via The Motley Fool
Where Will DocuSign Stock Be in 1 Year?
The e-signature service leader's stock could be bottoming out. 
Via The Motley Fool
Why DocuSign Stock Is Soaring Higher Today
Strong third-quarter results sent the stock climbing. 
Via The Motley Fool
DocuSign CEO's Turnaround Vision Debated Amid Earnings Beat
DocuSign stock popped Friday after it reported earnings and revenue that topped estimates amid sharply lowered expectations. 
Via Investor's Business Daily
Rivian, GlobalFoundries Joining Nasdaq 100 Index; Apple Chipmaker, China Stocks Falling Off
Rivian and GlobalFoundries lead Dec. 19 additions to the Nasdaq 100. 
Via Investor's Business Daily
Is DocuSign Stock on the Road to Recovery After Its Spectacular Fall From Grace?
The e-signature specialist increased investor confidence with a beat and raise. 
Via The Motley Fool
Annual Changes To The Nasdaq-100 Index For 2023
The Nasdaq-100 Index is composed of the 100 largest non-financial companies listed on The Nasdaq Stock Market. The reconstituted index (effective Dec. 19, 2022) has 6 new members, replacing such... 
Via Talk Markets
Most Active Equity Options For Midday - Friday, Dec. 9
Here are the most active equity options for midday. 
Via Talk Markets
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
Why Are Semiconductor Stocks Up Today?
Semiconductor stocks are climbing higher on Friday thanks to a major Q4 earnings beat from a major player in the market! 
Via InvestorPlace
12 Information Technology Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is Grom Social (GROM) Stock Down 62% Today?
Grom Social (GROM) stock is taking a beating on Friday after the social media company priced a public offering of its shares. 
Via InvestorPlace
5 Investors Betting Big on DocuSign (DOCU) Stock
DocuSign is surging after an impressive third-quarter earnings report. Here are the top institutional investors still betting on DOCU stock. 
Via InvestorPlace
Looking At DocuSign's Recent Unusual Options Activity
A whale with a lot of money to spend has taken a noticeably bullish stance on DocuSign. Looking at options history for DocuSign (NASDAQ:DOCU) we detected 14 strange trades. 
Via Benzinga
2 Top-Performing Nasdaq Tech Stocks in a Volatile Market
Even in a bear market, some companies perform well. 
Via The Motley Fool
Netflix To Rally Around 29%? Here Are 10 Other Price Target Changes For Friday
Wells Fargo raised Netflix, Inc. (NASDAQ: NFLX) price target from $300 to $400. Wells Fargo also upgraded the stock from Equal Weight to Overweight. Netflix shares rose 0.6% to close at $310.26 on... 
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 48.2% to $6.03 in pre-market trading after jumping over 20% on Thursday. Baudax Bio initiated Phase II clinical trial evaluating BX1000 in patients... 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback